MR编号 | DE/H/3405/001 |
---|
药品名称 | Rivastigmin STADA 4,6 mg/24 Stunden transdermales Pflaster |
---|
活性成分 | |
---|
剂型 | Transdermal patch |
---|
上市许可持有人 | Stadapharm GmbH
Stadastr. 2-18
61118 Bad Vilbel
Germany |
---|
参考成员国 - 产品名称 | Germany (DE) Rivastigmin STADA 4,6 mg/24 Stunden transdermales Pflaster |
---|
互认成员国 - 产品名称 | - Belgium (BE)
- United Kingdom (Northern Ireland) (XI)
- Denmark (DK)
- France (FR)
- Spain (ES)
- Sweden (SE)
Rivastigmin STADA
|
---|
许可日期 | 2013/01/18 |
---|
最近更新日期 | 2023/10/23 |
---|
药物ATC编码 | 申请类型 | - TypeLevel1:Abridged
- TypeLevel2:Initial Application
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | - Final Labelling | DE3403-07,3409,3411-12-Rivastigmin-lab. sachet-20130118Date of last change:2013/06/04
- Final Labelling | DE3403-07,3409,3411-12-Rivastigmin-lab. mulitpack-20130118Date of last change:2013/06/04
- Final Labelling | DE3403-07,3409,3411-12-Rivastigmin-lab. intermediate-20130118Date of last change:2013/06/04
- Final Labelling | DE3403-07,3409,3411-12-Rivastigmin-lab. carton-20130118Date of last change:2013/06/04
- PAR | PAREN_DE3403-07,3409,3411-12-Rivastigmin-20130118-finalDate of last change:2013/06/04
- Final PL | PALEN-DE3403-07,3409,3411-12-Rivastigmin-20130118Date of last change:2013/06/04
- Final SPC | SPCEN_DE3403-07,3409,3411-12-Rivastigmin-20130118Date of last change:2013/06/04
|
---|
市场状态 | Positive |
---|
|
---|